Overview of acute kidney manifestations and management of patients with COVID-19

Research output: Contribution to journalReview articlepeer-review


Since the start of the COVID-19 pandemic, several manifestations of kidney involvement associated with infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus have been described, including proteinuria, hematuria, and acute kidney injury. A growing body of literature has explored the risk factors and pathogenesis of COVID-19-associated acute kidney injury (AKI), including direct and indirect mechanisms, as well as early postdischarge outcomes that may result from various manifestations of kidney involvement. In this review, we explore the current state of knowledge of the epidemiology of COVID-19associated AKI, potential mechanisms and pathogenesis of AKI, and various management strategies for patients in the acute setting. We highlight how kidney replacement therapy for patients with COVID-19-associated AKI has been affected by the increasing demand for dialysis and how the postacute management of patients, including outpatient follow-up, is vitally important. We also review what is presently known about long-term kidney outcomes after the initial recovery from COVID-19. We provide some guidance as to the management of patients hospitalized with COVID-19 who are at risk for AKI as well as for future clinical research in the setting of COVID-19 and the significance of early identification of patients at highest risk for adverse kidney outcomes.

Original languageEnglish (US)
Pages (from-to)F403-F410
JournalAmerican Journal of Physiology - Renal Physiology
Issue number4
StatePublished - Oct 2021


  • Acute kidney injury
  • COVID-19
  • Chronic kidney disease
  • Dialysis

ASJC Scopus subject areas

  • Physiology
  • Urology


Dive into the research topics of 'Overview of acute kidney manifestations and management of patients with COVID-19'. Together they form a unique fingerprint.

Cite this